Estrostatin phosphate is indicated for use in advanced prostate cancer, especially in patients who are refractory to hormones and who have been shown to have poor efficacy in hormone therapy in the initial treatment.
Estrostatin phosphate should be administered by a person with experience in anti-tumor therapy, with a number of adverse reactions.

Market Analysis and Insights: Global Estramustine Phosphate Market
In 2020, the global Estramustine Phosphate market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Estramustine Phosphate Scope and Market Size
The global Estramustine Phosphate market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Estramustine Phosphate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Original Drug
Generic Drug

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Company
Pfizer
Natco Pharma
Pharmacia & Upjohn

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE